SCHEMBL13871879

SCHEMBL13871879

C=C1c2cc(Cl)ccc2CN1c1ccc2c(c1)N(C)CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 5/20 0.37
▸ NOTUM Q6P988 3/20 0.37
▸ HTR2A P28223 3/20 0.36
▸ ACHE P22303 2/20 0.36
▸ HTR2B P41595 2/20 0.35
▸ ADORA3 P0DMS8 2/20 0.33
▸ ADRA1A P35348 2/20 0.33
▸ OPRK1 P41145 2/20 0.33
▸ SLC6A3 Q01959 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ CHRNA4 P43681 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ CBLB Q13191 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13871921 0.91 ACHE (0.38) HTR2CNOTUMHTR2AACHEHTR2B
SCHEMBL13871856 0.85 CYP1A2 (0.35) HTR2CNOTUMHTR2AHTR2BMAPT
SCHEMBL13871851 0.85 NPC1 (0.37) HTR2CNOTUMHTR2APOLBMAPT
SCHEMBL13871899 0.82 MCHR1 (0.37) NOTUMMEN1KMT2ADRD2DRD1
SCHEMBL13872329 0.82 HTR1A (0.34) HTR2CHTR2AHTR2BMAPTTP53
SCHEMBL13871887 0.81 NOTUM (0.33) NOTUMMAPTDRD2MAPK1DRD3
SCHEMBL13871876 0.79 NOTUM (0.35) NOTUMSLC6A3KMT2ADRD2SLC6A2
SCHEMBL13871872 0.79 BACE1 (0.36) HTR2CNOTUMHTR2AHTR2BCYP3A4
SCHEMBL13872138 0.78 HTR2C (0.37) HTR2CHTR2AACHEPOLBCBLB
SCHEMBL13872246 0.77 CYP11B1 (0.43) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009042907-A1 ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-04-02 — — WO disclosed
Send feedback